Do you offer APBI for patients with invasive disease if there is high grade DCIS present in the lumpectomy specimen?
If a patient has a small luminal A invasive tumor resected to negative margins with admixed high-grade DCIS, does the high-grade DCIS component influence you to treat with whole breast radiation plus or minus a boost instead of APBI?
Answer from: Radiation Oncologist at Academic Institution
In these situations, I am still comfortable offering PBI to patients. DCIS is seen with invasive disease in a fair number of cases so this comes up frequently and as long as other criteria are met, I view this as appropriate for PBI.
Answer from: Radiation Oncologist at Academic Institution
Studies of PBI have given doses that appear to be biologically equivalent to that given by WBI regimens without a boost. However, this may not be sufficient to treat certain patients. The BIG 3–07/TROG 07.01 trial randomly allocated 1,608 patients with “non-low risk” DCIS with unin...
Comments
Radiation Oncologist at Cleveland Clinic I agree re: boost, it is important to note that 30...
Radiation Oncologist at Beth Israel Deaconess Medical Center Agree!
Radiation Oncologist at Cleveland Clinic Definitely a consideration. That being said, with ...
Answer from: Radiation Oncologist at Community Practice
It depends on the extent of the high grade in situ component. I would not recommend partial breast irradiation if it was a T1mic, or if EIC was reported.For invasive breast cancer, the presence of accompanying DCIS grade and extent can substantially influence local recurrence risk. In the most extre...
Comments
Radiation Oncologist at Associated Medical Professionals A great question that I think points at some knowl...